$MEDP

6 theses

bullish 0%neutral 0%bearish 100%

Avg return (1m)

-0.6%

Win rate (1m)

50% (4 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 18, 4:30 PM ET

$MEDPSEC Form 4bearish

Carley Brian T · Medpace Holdings, Inc. · 40d agono track record yet

Sold 5,000 @ $608.63 avg · $3,043,150 · 2026-08-19

Form 4: Carley Brian T sold MEDP

Carley Brian T (Director at Medpace Holdings, Inc.) reported an open-market sale of 5,000 shares of MEDP at an average $608.63, roughly $3,043,150, in a Form 4 filed 2026-08-21.

At post $620.75Now $612.33-1.4% since postedas of Sep 18, 4:30 PM ET

1d—

3d-0.1%

1w-3.2%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$MEDPSEC Form 4bearish

DAVENPORT FRED B JR · Medpace Holdings, Inc. · 40d agono track record yet

Sold 7,283 @ $606.15 avg · $4,414,590 · 2026-08-19

Form 4: DAVENPORT FRED B JR sold MEDP

DAVENPORT FRED B JR (Director at Medpace Holdings, Inc.) reported an open-market sale of 7,283 shares of MEDP at an average $606.15, roughly $4,414,590, in a Form 4 filed 2026-08-21.

At post $620.75Now $612.33-1.4% since postedas of Sep 18, 4:30 PM ET

1d—

3d-0.1%

1w-3.2%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$MEDPSEC Form 4bearish

Troendle August J. · President & CEO at Medpace Holdings, Inc. · 47d ago1 prior · awaiting results

Sold 11,824 @ $601.49 avg · $7,111,969 · 2026-08-12

Form 4: Troendle August J. sold MEDP

Troendle August J. (President & CEO at Medpace Holdings, Inc.) reported an open-market sale of 11,824 shares of MEDP at an average $601.49, roughly $7,111,969, in a Form 4 filed 2026-08-14.

At post $578.50Now $612.33+5.8% since postedas of Sep 18, 4:30 PM ET

1d—

3d+3.2%

1w+7.3%

1m+1.6%

3m—

6m—

1y—

View filing on SEC.gov →

$MEDPSEC Form 4bearish

McCarthy Cornelius P. III · Medpace Holdings, Inc. · 48d ago1 prior · awaiting results

Sold 1,140 @ $605.37 avg · $690,122 · 2026-08-11

Form 4: McCarthy Cornelius P. III sold MEDP

McCarthy Cornelius P. III (Director at Medpace Holdings, Inc.) reported an open-market sale of 1,140 shares of MEDP at an average $605.37, roughly $690,122, in a Form 4 filed 2026-08-13.

At post $587.33Now $612.33+4.3% since postedas of Sep 18, 4:30 PM ET

1d-1.5%

3d-1.5%

1w+4.3%

1m+0.0%

3m—

6m—

1y—

View filing on SEC.gov →

$MEDPSEC Form 4bearish

Troendle August J. · President & CEO at Medpace Holdings, Inc. · 49d ago1 prior · awaiting results

Sold 23,144 @ $604.25 avg · $13,984,854 · 2026-08-10

Form 4: Troendle August J. sold MEDP

Troendle August J. (President & CEO at Medpace Holdings, Inc.) reported an open-market sale of 23,144 shares of MEDP at an average $604.25, roughly $13,984,854, in a Form 4 filed 2026-08-12.

At post $596.98Now $612.33+2.6% since postedas of Sep 18, 4:30 PM ET

1d-1.6%

3d-3.1%

1w+1.9%

1m-1.6%

3m—

6m—

1y—

View filing on SEC.gov →

$MEDPSEC Form 4bearish

McCarthy Cornelius P. III · Medpace Holdings, Inc. · 50d ago1 prior · awaiting results

Sold 795 @ $585.07 avg · $465,131 · 2026-08-07

Form 4: McCarthy Cornelius P. III sold MEDP

McCarthy Cornelius P. III (Director at Medpace Holdings, Inc.) reported an open-market sale of 795 shares of MEDP at an average $585.07, roughly $465,131, in a Form 4 filed 2026-08-11.

At post $596.98Now $612.33+2.6% since postedas of Sep 18, 4:30 PM ET

1d—

3d-3.1%

1w-1.1%

1m-2.3%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.